Semaglutide, liraglutide, and dulaglutide have all demonstrated modest systolic blood pressure reductions in clinical studies
"Today, the onus is on patients to know all the right questions to ask, jump through hoops, and find the right person from their insurer, doctor's office, or pharmacy who can get them answers about their coverage
Dushay J, Chui PC, Gopalakrishnan GS et al (2010) Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease
Together, they offer a holistic approach to weight loss that addresses multiple aspects of metabolic health
Contrast to peptides, small-molecule GLP-1 agonists like orforglipron are synthesized via conventional chemical routes in organic solvents, which can be scaled more like typical pharmaceuticals (crystallization, distillation, continuous reactors)